164 related articles for article (PubMed ID: 25008861)
1. KIR-associated protection from CMV replication requires pre-existing immunity: a prospective study in solid organ transplant recipients.
Gonzalez A; Schmitter K; Hirsch HH; Garzoni C; van Delden C; Boggian K; Mueller NJ; Berger C; Villard J; Manuel O; Meylan P; Stern M; Hess C;
Genes Immun; 2014 Oct; 15(7):495-9. PubMed ID: 25008861
[TBL] [Abstract][Full Text] [Related]
2. Protection From Varicella Zoster in Solid Organ Transplant Recipients Carrying Killer Cell Immunoglobulin-Like Receptor B Haplotypes.
Schmied L; Terszowski G; Gonzalez A; Schmitter K; Hirsch HH; Garzoni C; van Delden C; Boggian K; Mueller NJ; Berger C; Villard J; Manuel O; Meylan P; Hess C; Stern M;
Transplantation; 2015 Dec; 99(12):2651-5. PubMed ID: 26050016
[TBL] [Abstract][Full Text] [Related]
3. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56
Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS
Front Immunol; 2020; 11():1231. PubMed ID: 32625211
[TBL] [Abstract][Full Text] [Related]
4. KIR and HLA interactions are associated with control of primary CMV infection in solid organ transplant recipients.
van Duin D; Avery RK; Hemachandra S; Yen-Lieberman B; Zhang A; Jain A; Butler RS; Barnard J; Schold JD; Fung J; Askar M
Am J Transplant; 2014 Jan; 14(1):156-62. PubMed ID: 24369024
[TBL] [Abstract][Full Text] [Related]
5. Killer-cell immunoglobulin-like receptors and cytomegalovirus reactivation during late pregnancy.
Alvarado-Hernández DL; Benítez-Sánchez A; Rodríguez-Cuevas JS; Rosales-Saavedra T; Guerra-Palomares SE; Comas-García A; Noyola DE; García-Sepúlveda CA
Int J Immunogenet; 2016 Aug; 43(4):189-99. PubMed ID: 27277336
[TBL] [Abstract][Full Text] [Related]
6. The effect of single and combined activating killer immunoglobulin-like receptor genotypes on cytomegalovirus infection and immunity after hematopoietic cell transplantation.
Zaia JA; Sun JY; Gallez-Hawkins GM; Thao L; Oki A; Lacey SF; Dagis A; Palmer J; Diamond DJ; Forman SJ; Senitzer D
Biol Blood Marrow Transplant; 2009 Mar; 15(3):315-25. PubMed ID: 19203722
[TBL] [Abstract][Full Text] [Related]
7. KIR and Human Leukocyte Antigen Genotype Associated Risk of Cytomegalovirus Disease in Renal Transplant Patients.
Michelo CM; van der Meer A; Tijssen HJ; Zomer R; Stelma F; Hilbrands LB; Joosten I
Transplantation; 2015 Jul; 99(7):1506-13. PubMed ID: 25427165
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of telomeric KIR genes and their association with CMV infection in kidney transplant recipients.
Farzamikia N; Hejazian SM; Haghi M; Hejazian SS; Zununi Vahed S; Ardalan M
Immunogenetics; 2022 Apr; 74(2):207-212. PubMed ID: 35091752
[TBL] [Abstract][Full Text] [Related]
9. Telomeric rather than centromeric activating KIR genes protect from cytomegalovirus infection after kidney transplantation.
Stern M; Hadaya K; Hönger G; Martin PY; Steiger J; Hess C; Villard J
Am J Transplant; 2011 Jun; 11(6):1302-7. PubMed ID: 21486386
[TBL] [Abstract][Full Text] [Related]
10. Recipient-donor KIR ligand matching prevents CMV reactivation post-haploidentical T cell-replete transplantation.
Zhao XY; Luo XY; Yu XX; Zhao XS; Han TT; Chang YJ; Huo MR; Xu LP; Zhang XH; Liu KY; Li D; Jiang ZF; Huang XJ
Br J Haematol; 2017 Jun; 177(5):766-781. PubMed ID: 28466469
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.
Hadaya K; de Rham C; Bandelier C; Bandelier C; Ferrari-Lacraz S; Jendly S; Berney T; Buhler L; Kaiser L; Seebach JD; Tiercy JM; Martin PY; Villard J
Am J Transplant; 2008 Dec; 8(12):2674-83. PubMed ID: 19032228
[TBL] [Abstract][Full Text] [Related]
12. The number of activating KIR genes inversely correlates with the rate of CMV infection/reactivation in kidney transplant recipients.
Stern M; Elsässer H; Hönger G; Steiger J; Schaub S; Hess C
Am J Transplant; 2008 Jun; 8(6):1312-7. PubMed ID: 18444913
[TBL] [Abstract][Full Text] [Related]
13. Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.
Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska-Jakubowicz A; Gozdowska J; Ciszek M; Pazik J; Ostaszewska A; Kosieradzki M; Nowak J; Durlik M
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696053
[TBL] [Abstract][Full Text] [Related]
14. [The association of killer cell immunoglobulin like receptor gene polymorphism with cytomegalovirus infection after hematopoietic stem cell transplantation].
Wu XJ; He J; Wu DP; Bao XJ; Xu C; Zhou HF; Sun AN; Han Y; Tang XW; Fu ZZ; Ma X
Zhonghua Nei Ke Za Zhi; 2013 Feb; 52(2):161-5. PubMed ID: 23967614
[TBL] [Abstract][Full Text] [Related]
15. Expression of activating KIR2DS2 and KIR2DS4 genes after hematopoietic cell transplantation: relevance to cytomegalovirus infection.
Gallez-Hawkins GM; Franck AE; Li X; Thao L; Oki A; Gendzekhadze K; Dagis A; Palmer J; Nakamura R; Forman SJ; Senitzer D; Zaia JA
Biol Blood Marrow Transplant; 2011 Nov; 17(11):1662-72. PubMed ID: 21596150
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.
Foley B; Cooley S; Verneris MR; Pitt M; Curtsinger J; Luo X; Lopez-Vergès S; Lanier LL; Weisdorf D; Miller JS
Blood; 2012 Mar; 119(11):2665-74. PubMed ID: 22180440
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection.
Charoudeh HN; Terszowski G; Czaja K; Gonzalez A; Schmitter K; Stern M
Eur J Immunol; 2013 Feb; 43(2):480-7. PubMed ID: 23161492
[TBL] [Abstract][Full Text] [Related]
18. Expression of killer cell immunoglobulin-like receptors (KIRs) by natural killer cells during acute CMV infection after kidney transplantation.
de Rham C; Hadaya K; Bandelier C; Ferrari-Lacraz S; Villard J
Transpl Immunol; 2014 Sep; 31(3):157-64. PubMed ID: 25158213
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analyses.
Toupance O; Bouedjoro-Camus MC; Carquin J; Novella JL; Lavaud S; Wynckel A; Jolly D; Chanard J
Transpl Int; 2000; 13(6):413-9. PubMed ID: 11140239
[TBL] [Abstract][Full Text] [Related]
20. Killer immunoglobulin-like receptor gene repertoire influences viral load of primary human cytomegalovirus infection in renal transplant patients.
Jones DC; Peacock S; Hughes D; Traherne JA; Allen RL; Barnardo MC; Friend P; Taylor CJ; Fuggle S; Trowsdale J; Young NT
Genes Immun; 2014 Dec; 15(8):562-8. PubMed ID: 25253288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
